These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32738155)

  • 1. Immunohistochemical characterization of immune cell infiltration in paediatric and adult Langerhans cell histiocytosis.
    Paredes SEY; Almeida LY; Trevisan GL; Polanco XBJ; Silveira HA; Vilela Silva E; Segato RAB; da Silva LAB; Chahud F; León JE
    Scand J Immunol; 2020 Dec; 92(6):e12950. PubMed ID: 32738155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated Conventional T-Cells Are Present in Langerhans Cell Histiocytosis Lesions Despite the Presence of Immune Suppressive Cytokines.
    Quispel WT; Stegehuis-Kamp JA; Santos SJ; Egeler RM; van Halteren AG
    J Interferon Cytokine Res; 2015 Oct; 35(10):831-9. PubMed ID: 26381039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foxp3
    Mitchell J; Kelly J; Kvedaraite E; von Bahr Greenwood T; Henter JI; Pellicci DG; Berzins SP; Kannourakis G
    Clin Immunol; 2020 Jun; 215():108418. PubMed ID: 32283322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF1R Is Required for Differentiation and Migration of Langerhans Cells and Langerhans Cell Histiocytosis.
    Lonardi S; Scutera S; Licini S; Lorenzi L; Cesinaro AM; Gatta LB; Castagnoli C; Bollero D; Sparti R; Tomaselli M; Medicina D; Calzetti F; Cassatella MA; Facchetti F; Musso T; Vermi W
    Cancer Immunol Res; 2020 Jun; 8(6):829-841. PubMed ID: 32238382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells.
    Allen CE; Li L; Peters TL; Leung HC; Yu A; Man TK; Gurusiddappa S; Phillips MT; Hicks MJ; Gaikwad A; Merad M; McClain KL
    J Immunol; 2010 Apr; 184(8):4557-67. PubMed ID: 20220088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 Is Expressed in Neoplastic Cells of Langerhans Cell Histiocytosis but Not Reactive Langerhans Cell Proliferations.
    Shanmugam V; Craig JW; Hornick JL; Morgan EA; Pinkus GS; Pozdnyakova O
    Am J Surg Pathol; 2017 Oct; 41(10):1390-1396. PubMed ID: 28622183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphoproteomics provides support for TGF-β pathway signaling in the osteoclastogenesis and immune dysregulation of osteolytic Langerhans cell histiocytosis.
    Alexandrescu S; Tatevian N; Czerniak BA; Covinsky MH; Burns NK; Brown RE
    Int J Clin Exp Pathol; 2012; 5(6):503-11. PubMed ID: 22949932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival.
    Nagorsen D; Voigt S; Berg E; Stein H; Thiel E; Loddenkemper C
    J Transl Med; 2007 Nov; 5():62. PubMed ID: 18047662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress in the Treatment of Adult Langerhans Cell Histiocytosis --Review].
    Tian ZZ; Cui YJ; Peng HL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):970-974. PubMed ID: 35680836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential In situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment.
    Egeler RM; Favara BE; van Meurs M; Laman JD; Claassen E
    Blood; 1999 Dec; 94(12):4195-201. PubMed ID: 10590064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X?
    Berres ML; Merad M; Allen CE
    Br J Haematol; 2015 Apr; 169(1):3-13. PubMed ID: 25430560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of Langerhans cells in Langerhans cell histiocytosis.
    Geissmann F; Lepelletier Y; Fraitag S; Valladeau J; Bodemer C; Debré M; Leborgne M; Saeland S; Brousse N
    Blood; 2001 Mar; 97(5):1241-8. PubMed ID: 11222366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Langerhans cell histiocytosis in Chinese adults: absence of BRAF mutations and increased FOXP3(+) regulatory T cells.
    Tong C; Jia X; Jia Y; He Y
    Int J Clin Exp Pathol; 2014; 7(6):3166-73. PubMed ID: 25031736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expansion of regulatory T cells in patients with Langerhans cell histiocytosis.
    Senechal B; Elain G; Jeziorski E; Grondin V; Patey-Mariaud de Serre N; Jaubert F; Beldjord K; Lellouch A; Glorion C; Zerah M; Mary P; Barkaoui M; Emile JF; Boccon-Gibod L; Josset P; Debré M; Fischer A; Donadieu J; Geissmann F
    PLoS Med; 2007 Aug; 4(8):e253. PubMed ID: 17696642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte sub-populations and non-Langerhans' cell monocytoid cells in pulmonary Langerhans' cell histiocytosis.
    Nagarjun Rao R; Chang CC; Tomashefski JF
    Pathol Res Pract; 2008; 204(5):315-22. PubMed ID: 18337020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating CD1c+ myeloid dendritic cells are potential precursors to LCH lesion CD1a+CD207+ cells.
    Lim KPH; Milne P; Poidinger M; Duan K; Lin H; McGovern N; Abhyankar H; Zinn D; Burke TM; Eckstein OS; Chakraborty R; Sengal A; Scull B; Newell E; Merad M; McClain KL; Man TK; Ginhoux F; Collin M; Allen CE
    Blood Adv; 2020 Jan; 4(1):87-99. PubMed ID: 31899802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Langerhans cells in Langerhans cell histiocytosis and peripheral adenocarcinomas of the lung.
    Colasante A; Poletti V; Rosini S; Ferracini R; Musiani P
    Am Rev Respir Dis; 1993 Sep; 148(3):752-9. PubMed ID: 7690210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apparent Lack of
    Kemps PG; Zondag TC; Steenwijk EC; Andriessen Q; Borst J; Vloemans S; Roelen DL; Voortman LM; Verdijk RM; van Noesel CJM; Cleven AHG; Hawkins C; Lang V; de Ru AH; Janssen GMC; Haasnoot GW; Franken KLMC; van Eijk R; Solleveld-Westerink N; van Wezel T; Egeler RM; Beishuizen A; van Laar JAM; Abla O; van den Bos C; van Veelen PA; van Halteren AGS
    Front Immunol; 2019; 10():3045. PubMed ID: 31998317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRAFV600E and MAP2K1 mutations in Langerhans cell histiocytosis occur predominantly in children.
    Zeng K; Ohshima K; Liu Y; Zhang W; Wang L; Fan L; Li M; Li X; Wang Z; Guo S; Yan Q; Guo Y
    Hematol Oncol; 2017 Dec; 35(4):845-851. PubMed ID: 27597420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups.
    Berres ML; Lim KP; Peters T; Price J; Takizawa H; Salmon H; Idoyaga J; Ruzo A; Lupo PJ; Hicks MJ; Shih A; Simko SJ; Abhyankar H; Chakraborty R; Leboeuf M; Beltrão M; Lira SA; Heym KM; Bigley V; Collin M; Manz MG; McClain K; Merad M; Allen CE
    J Exp Med; 2014 Apr; 211(4):669-83. PubMed ID: 24638167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.